BREAKING NEWS: HGS rejects GSK $2.60 billion takeover bid

Article Date: 19/04/2012 10:03
BREAKING NEWS: HGS rejects GSK $2.60 billion takeover bid

Vacancy Search

Quick job search

Advanced Search

Latest News

Upcoming events: Bristol-Myers and GW Pharma approach key data readouts

Welcome to your weekly digest of approaching regulatory and clinical readouts. Keenly awaited lung cancer data will emerge next week on Bristol-Myers Squibb’s Opdivo; the company has already...

£132m investment in cancer research at Oxford Uni

£132m investment in cancer research at Oxford Uni

Lilly profits pummelled by generic competition

Lilly profits pummelled by generic competition

Celgene profits leap on multiple myeloma drugs

Celgene profits leap on multiple myeloma drugs

UK £230 million investment to 'revolutionise research'

UK £230 million investment to 'revolutionise research'

Medicines not goods like any other, says new EU president

Medicines not goods like any other, says new EU president

Uproar as doctors get £55 per dementia diagnosis

Uproar as doctors get £55 per dementia diagnosis

Amgen lacks freshness, but is by no means the worst offender

Amgen, heavily castigated this week for overreliance on old products, must feel like it has been unfairly targeted. After all, it is hardly alone in this predicament.

UPDATE: NHS leaders call for £8bn a year to fill cash hole

UPDATE: NHS leaders call for £8bn a year to fill cash hole

Provisional NHS green light for Bayer's Xarelto

Provisional NHS green light for Bayer's Xarelto
more news